Phase II Trial of Bevacizumab Monotherapy in Pancreatic Neuroendocrine Tumors. Zhu M, Costello BA, Yin J, Pettinger AM, et al. Pancreas 2021;50:1435-1439.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhu M, Costello BA, Yin J, Pettinger AM, et al. Phase II Trial of Bevacizumab Monotherapy in Pancreatic Neuroendocrine Tumors. Pancreas 2021;50:1435-1439.
PMID: 35041344